Report overview
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Screening. This report contains market size and forecasts of Breast Cancer Screening in global, including the following market information:
Global Breast Cancer Screening Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Breast Cancer Screening Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Breast Cancer Screening companies in 2022 (%)
The global Breast Cancer Screening market was valued at US$ 49 million in 2022 and is projected to reach US$ 85 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.
We surveyed the Breast Cancer Screening manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Screening Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Breast Cancer Screening Market Segment Percentages, by Type, 2022 (%)
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Global Breast Cancer Screening Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Breast Cancer Screening Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Breast Cancer Screening Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Breast Cancer Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Screening revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Breast Cancer Screening revenues share in global market, 2022 (%)
Key companies Breast Cancer Screening sales in global market, 2018-2023 (Estimated), (Units)
Key companies Breast Cancer Screening sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Cancer Screening, market overview.
Chapter 2: Global Breast Cancer Screening market size in revenue and volume.
Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Breast Cancer Screening capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
